🧪 UPDATED DAILY FROM CLINICALTRIALS.GOVSynced Apr 1

Find Clinical Trials for Your Rare Disease

4+ recruiting trials across all rare diseases. Filter by phase, location, and condition.

ℹ
Clinical trial records are synced from ClinicalTrials.gov.
Report missing data
Clear

Showing 4 of 4 recruiting trials for “obsolete-chondrodysplastic-malformation-syndrome”

Phase 2RecruitingNCT06630221 ↗

Eltrombopag as a Novel Therapeutic Approach for Low-risk MDS and CMML With TET2 Mutations

👨‍⚕️ Abhay Singh, MD, MPH, Case Comprehensive Cancer Center, Cleveland Clinic Taussig Cancer Institute📍 1 site📅 Started Jun 2025View details ↗
Phase 1, PHASE2RecruitingNCT06548230 ↗

A Phase 1B/2A Trial of NADUNOLIMAB in Combination With Azacitidine (With/Without Venetoclax) in Patients With Myelodysplastic Syndrome (MDS) and Acute Myelogenous Leukemia (AML)

👨‍⚕️ Gautam Borthakur, MBBS, M.D. Anderson Cancer Center📍 1 site📅 Started Mar 2025View details ↗
Phase 2RecruitingNCT06802315 ↗

Intensity Modulated Total Marrow Irradiation in Fully Human Leukocyte Antigen (HLA)-Matched and Partially-HLA Mismatched Allogeneic Transplantation Patients With High-Risk Acute Myeloid Leukemia (AML), Chronic Myeloid Leukemia (CML), and Myelodysplastic Syndrome (MDS)

👨‍⚕️ Matias Sanchez, MD, University of Illinois at Chicago📍 1 site📅 Started Feb 2025View details ↗
NARecruitingNCT06886425 ↗

Involvement of CDA and/or dCK Metabolizing Enzymes in the Response to Azacytidine Treatment of Patients With Hematologic Malignancies

🏥 Assistance Publique Hopitaux De Marseille📍 1 site📅 Started Jun 2021View details ↗

Get alerts when new trials open

Create a free account to follow conditions and receive trial notifications.

Create free account →